The efficacy and safety of onartuzumab in patients with solid cancers: A meta-analysis of randomized trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Works by Kim, Dalyong
Results: 14
1
2
Primary tumor location predicts poor clinical outcome with cetuximab in RAS wild-type metastatic colorectal cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
3
Pneumocystis jirovecii pneumonia in patients with lung cancer receiving immune checkpoint inhibitors: a retrospective nationwide population-based cohort study from South Korea.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02627-8
- By:
- Publication type:
- Article
4
Analysis of Cancer Patient Decision-Making and Health Service Utilization after Enforcement of the Life-Sustaining Treatment Decision-Making Act in Korea.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 1, p. 20, doi. 10.4143/crt.2021.131
- By:
- Publication type:
- Article
5
Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 4, p. 1549, doi. 10.4143/crt.2019.086
- By:
- Publication type:
- Article
6
Use of a High-Throughput Genotyping Platform (OncoMap) for RAS Mutational Analysis to Predict Cetuximab Efficacy in Patients with Metastatic Colorectal Cancer.
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 1, p. 37, doi. 10.4143/crt.2016.069
- By:
- Publication type:
- Article
7
Consistent Response on Challenge and Rechallenge of Liposomal Irinotecan in a Patient with Metastatic Pancreatic Adenocarcinoma Previously Treated with Gemcitabine plus Nab-Paclitaxel: A Case Report.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
8
Navigating shared decision-making after the Life-Sustaining Treatment Decision Act: a qualitative study of in-depth interviews with terminal cancer patients, families, and healthcare professionals.
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 12, p. 1, doi. 10.1007/s00520-024-08975-5
- By:
- Publication type:
- Article
9
Add-On Treatment with Gliclazide for Cancer Patients with Type 2 Diabetes Undergoing Cyclic Glucocorticoid-Containing Chemotherapy.
- Published in:
- Biomedicines, 2025, v. 13, n. 5, p. 1101, doi. 10.3390/biomedicines13051101
- By:
- Publication type:
- Article
10
HER2 Amplification and Cetuximab Efficacy in Patients With Metastatic Colorectal Cancer Harboring Wild-type RAS and BRAF.
- Published in:
- Clinical Colorectal Cancer, 2017, v. 16, n. 3, p. e147, doi. 10.1016/j.clcc.2017.01.005
- By:
- Publication type:
- Article
11
Reactivation of Varicella-Zoster Virus in Patients with Lung Cancer Receiving Immune Checkpoint Inhibitors: Retrospective Nationwide Population-Based Cohort Study from South Korea.
- Published in:
- Cancers, 2024, v. 16, n. 8, p. 1499, doi. 10.3390/cancers16081499
- By:
- Publication type:
- Article
12
Incidence and Clinical Outcomes of Febrile Neutropenia in Adult Cancer Patients with Chemotherapy Using Korean Nationwide Health Insurance Database.
- Published in:
- Yonsei Medical Journal, 2021, v. 62, n. 6, p. 479, doi. 10.3349/ymj.2021.62.6.479
- By:
- Publication type:
- Article
13
Awareness of Doctors' Shared Decision-Making in Life-Sustaining Care Decisions.
- Published in:
- Journal of Hospice & Palliative Care, 2021, v. 24, n. 4, p. 204, doi. 10.14475/jhpc.2021.24.4.204
- By:
- Publication type:
- Article
14
Primary tumor location predicts poor clinical outcome with cetuximab in RAS wild-type metastatic colorectal cancer.
- Published in:
- BMC Gastroenterology, 2017, v. 17, n. 1, p. 1, doi. 10.1186/s12876-017-0694-6
- By:
- Publication type:
- Article